StockNews.com started coverage on shares of Ekso Bionics (NASDAQ:EKSO – Free Report) in a research note published on Monday morning. The brokerage issued a sell rating on the stock. EKSO has been the topic of several other research reports. 500.com reissued a reiterates rating on shares of Ekso Bionics in a research report on Friday, […]
/PRNewswire/ The "Human Augmentation in Healthcare: Bionics, Organ and Body Part Replacement, Exoskeletons, and Robotics 2023 - 2028" report has been added.
StockNews.com began coverage on shares of Ekso Bionics (NASDAQ:EKSO – Free Report) in a report published on Sunday morning. The brokerage issued a sell rating on the stock. EKSO has been the subject of a number of other research reports. 500.com reissued a reiterates rating on shares of Ekso Bionics in a report on Friday, […]
Stock analysts at StockNews.com assumed coverage on shares of Ekso Bionics (NASDAQ:EKSO – Get Rating) in a report released on Sunday. The brokerage set a “sell” rating on the stock. EKSO has been the topic of several other reports. HC Wainwright restated a “buy” rating and issued a $9.00 price target on shares of Ekso […]
StockNews.com assumed coverage on shares of Ekso Bionics (NASDAQ:EKSO – Get Rating) in a report released on Saturday. The brokerage issued a sell rating on the stock. A number of other research analysts have also commented on the company. 500.com reiterated a reiterates rating on shares of Ekso Bionics in a research report on Friday, […]